PF785 CHANGING CAUSES OF MORTALITY IN TDT DURING THE ERA OF ORAL CHELATION THERAPY FROM 2000 TO 2018

Paul Telfer(Queen Mary University of London), Marina Kleanthous(Cyprus Institute of Neurology and Genetics), Anita Kolnagou(Paphos General Hospital), Maria Sitarou(Larnaca College), M Hadjigavriel(Limassol General Hospital), Petros Kountouris(Cyprus Institute of Neurology and Genetics), S. Christou(Palmetto Hematology Oncology)
Cited by 4


Related Papers